491 POSTER Trageting XIAP in paediatric cancers
Sarah V. Holt(Pharma Nord (United Kingdom)), J G.W.J., Caroline Dive(University of Manchester), Richard A. Houghten(Unknown), Janet Reed, Karen E. Brookes(Cancer Research UK Manchester Institute), Deema Hussein(King Abdulaziz University), Kate Welsh(Ionis Pharmaceuticals (United States)), Clemencia Pinilla
Cited by 0
Related Papers
Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer
|Journal of Thoracic Oncology|2021|642
Generation of protein-reactive antibodies by short peptides is an event of high frequency: implications for the structural basis of immune recognition.
|Proceedings of the National Academy of Sciences|1983|377
Bub1 is required for kinetochore localization of BubR1, Cenp-E, Cenp-F and Mad2, and chromosome congression
|Journal of Cell Science|2004|344
Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial
|The Lancet Oncology|2015|282
Vasculogenic mimicry in small cell lung cancer
|Nature Communications|2016|243